Dominique Bron

Q: What Schools Are Affiliated With Dominique Bron

Dominique Bron is affiliated with the following schools: Leiden University, Université libre de Bruxelles, University of California, Berkeley, Université de Montréal, University of Oxford, University of Pavia, Stanford University

Dominique Bron's AcademicInfluence.com Rankings

Dominique Bron

Computer Science

#10003

World Rank

#10494

Historical Rank

Computational Linguistics

#2497

World Rank

#2522

Historical Rank

Machine Learning

#4526

World Rank

#4577

Historical Rank

Artificial Intelligence

#4884

World Rank

#4948

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Dominique Bron's Degrees

Masters Artificial Intelligence Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Dominique Bron Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dominique Bron's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. (1995) (2257)
CD4⁺ follicular helper T cell infiltration predicts breast cancer survival. (2013) (712)
Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and Plasticity (2005) (443)
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial (2017) (388)
Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression (1992) (384)
Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. (2004) (317)
Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. (2013) (285)
Involved-field radiotherapy for advanced Hodgkin's lymphoma. (2003) (276)
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. (2011) (263)
Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells (1998) (260)
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. (2009) (258)
Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. (2010) (250)
CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia (1999) (250)
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. (1998) (233)
Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. (1996) (229)
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response. (1995) (218)
Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. (1998) (201)
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma (2017) (196)
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. (2009) (193)
Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells. (2016) (192)
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus (2020) (185)
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial. (2016) (169)
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. (2008) (168)
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP (2008) (158)
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial. (1998) (155)
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study. (2001) (154)
Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. (2010) (151)
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation. (2012) (148)
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. (2014) (147)
Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool (2005) (138)
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer (2003) (138)
Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. (2002) (135)
Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. (1988) (133)
The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. (2011) (131)
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. (2011) (128)
Human marrow mesenchymal stem cell culture: serum‐free medium allows better expansion than classical α‐MEM medium (2006) (127)
Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. (2004) (124)
Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. (2013) (117)
Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming (2012) (114)
Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. (1991) (111)
Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. (2010) (98)
Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells (2008) (93)
Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue. (2015) (92)
CD 4 + follicular helper T cell infiltration predicts breast cancer survival (2013) (91)
Biological basis of anemia. (2001) (91)
A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. (2011) (90)
Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells (2013) (89)
Erythrocyte Sedimentation Rate Predicts Early Relapse and Survival in Early-Stage Hodgkin Disease (1991) (88)
Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. (2009) (88)
Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells. (1999) (83)
Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. (2012) (75)
HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance (2012) (73)
Screening for psychiatric disorders in a lymphoma out-patient population. (1992) (72)
Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review (2017) (72)
EXPERIMENTATION ON HUMAN BEINGS (1953) (72)
Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. (1993) (71)
A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. (2008) (70)
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. (2006) (70)
Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab (2015) (68)
Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study (2003) (67)
In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. (2009) (67)
Production of human monoclonal IgG antibodies against Rhesus (D) antigen. (1984) (67)
Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. (2010) (62)
The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network (2016) (60)
Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications (2017) (59)
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B‐chronic lymphocytic leukaemia cells (2009) (57)
Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease1 (2002) (57)
Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts (2018) (56)
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments (2012) (55)
Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia (2015) (53)
Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. (2012) (53)
Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation (2009) (53)
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. (2017) (52)
Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. (2005) (52)
Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies (2003) (50)
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. (2005) (49)
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia. (2004) (49)
Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration. (2013) (48)
Heterogenous response of B lymphocytes to transforming growth factor‐beta in B‐cell chronic lymphocytic leukaemia: correlation with the expression of TGF‐β receptors (1997) (47)
Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features (2019) (46)
Reduction of B cell turnover in chronic lymphocytic leukaemia (2008) (45)
Isolation of adipose-derived stromal cells without enzymatic treatment: expansion, phenotypical, and functional characterization. (2014) (44)
Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition. (2015) (43)
Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. (2007) (43)
Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis (2009) (42)
Significance of TIM3 expression in cancer: From biology to the clinic. (2019) (42)
Comparison of the coexpression of cd38, cd33 and hla‐dr antigens on cd34+ purified cells from human cord blood and bone marrow (1995) (41)
Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells (2015) (40)
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. (2002) (40)
Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium (2018) (40)
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study (2021) (39)
The effect of Epoetin alfa on quality of life in anemic cancer patients. (1999) (38)
PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients). (1991) (38)
Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study (2008) (38)
Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. (1994) (38)
Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study. (2015) (38)
Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma. (2013) (37)
Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA (2009) (37)
Tandem autologous stem cell transplantation improves outcome in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the Chronic Malignancies Working Party of EBMT. (2019) (36)
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data (2020) (35)
Early induction of apoptosis in B‐chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase‐3 and no protection by survival factors (2001) (35)
Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis (2015) (35)
Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. (1996) (34)
Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival? (2016) (33)
Disciplinary Approach to Understanding Cytomegalovirus Disease (1993) (33)
Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation (2018) (31)
Therapeutic Drug Monitoring of Posaconazole in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome (2012) (31)
Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients (2008) (31)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells (2010) (31)
Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies (2017) (31)
Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation (2000) (30)
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma (2015) (30)
Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work (1993) (29)
Hydroxychloroquine-induced Apoptosis of Chronic Lymphocytic Leukemia Involves Activation of Caspase-3 and Modulation of Bcl-2/bax/ratio (2002) (29)
A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia Patients (2010) (29)
Aging and blood disorders: new perspectives, new challenges (2015) (28)
Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report (2008) (28)
Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome (2017) (28)
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. (1989) (27)
Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection. (1996) (27)
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma. (1994) (25)
Amphotericin B Encapsulated in Liposomes Administered to Cancer Patients a (1988) (25)
Factors associated with self‐perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study (2017) (25)
Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles (2020) (25)
Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration (2021) (24)
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance (2016) (24)
Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties. (2016) (24)
Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging? (1999) (24)
Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group (2010) (23)
Maintenance with rituximab after autologous stem cell transplantation in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL): CORAL final analysis. (2011) (22)
Serum erythropoietin in chronic lymphocytic leukaemia (1996) (22)
TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia. (1998) (22)
Avoiding False Positive Antigen Detection by Flow Cytometry on Blood Cell Derived Microparticles: The Importance of an Appropriate Negative Control (2015) (22)
Multicenter implementation of geriatric assessment in Belgian patients with cancer: a survey on treating physicians' general experiences and expectations. (2014) (21)
In vivo production of mesenchymal stromal cells after injection of autologous platelet-rich plasma activated by recombinant human soluble tissue factor in the bone marrow of healthy volunteers. (2014) (19)
De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema (2005) (19)
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report (2021) (19)
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). (2013) (18)
Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery (2018) (18)
Human CD8+CD25 +CD127 low regulatory T cells: microRNA signature and impact on TGF‐β and IL‐10 expression (2019) (18)
The prevalence and implications of elderly inpatients' desire for a formal psychological help at the start of cancer treatment (2015) (18)
Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells. (2003) (17)
PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads (2021) (17)
Clinical Studies with a THC Analog (BRL‐4664) in the Prevention of Cisplatin‐Induced Vomiting (1981) (17)
Vitamin E and the prevention of atherosclerosis. (2001) (17)
Stem cell transplantation from identical twins in patients with myelodysplastic syndromes (2005) (17)
Multiple organ failure during interleukin-2 administration and LAK cells infusion (2004) (17)
Immunological definition of acute minimally differentiated myeloid leukemia (MO) and acute undifferentiated leukemia (AUL). (1995) (16)
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group. (1997) (16)
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT (2014) (16)
Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients. (1995) (15)
Impact of life-threatening risk information on the evolution of patients' anxiety and risk recall: the specific context of informed consent for experimental stem cell transplant. (2009) (15)
Viral‐induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant (2017) (15)
Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors (1990) (15)
Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients (2014) (15)
Health related quality of life in older patients with solid tumors and prognostic factors for decline. (2019) (15)
Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantation. (1998) (15)
Unmet needs in the scientific approach to older patients with lymphoma (2017) (14)
Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia (1990) (14)
Peripheral neuropathy associated with fluoroquinolones (1992) (14)
New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways (2021) (14)
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma. (1995) (14)
The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells (2020) (14)
Final Results of a Randomized Phase 2 Multicenter Study of Two Bortezomib Schedules In Patients with Recurrent or Refractory Follicular Lymphoma. Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study FL-05 (2010) (13)
Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming (2017) (13)
Graft-versus-host disease. (1994) (12)
Total parenteral nutrition‐induced cholestasis mimicking large bile duct obstruction (1982) (12)
Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors. (2020) (12)
A phase I, first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies. (2014) (12)
Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL‐3), IL‐6, granulocyte‐macrophage colony stimulating factor (GM‐CSF) and stem cell factor (SCF) in serum‐supplemented and serum‐free medium (1994) (12)
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis. (2016) (12)
Immunological impact of Wharton’s Jelly mesenchymal stromal cells and natural killer cell co-culture (2018) (12)
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013) (2015) (12)
Advanced Glycation End-Products-, C-Type Lectin- and Cysteinyl/ Leukotriene-Receptors in Distinct Mesenchymal Stromal Cell Populations: Differential Transcriptional Profiles in Response to Inflammation (2018) (11)
Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2 (r-Met Hu IL-2 [ala 125]). (1991) (11)
Scientific basis and criticism of current therapy of acute leukemia. (1982) (11)
Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study (2019) (11)
Ex vivo expansion of CD34 + CD38- cord blood cells. (1997) (11)
Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model. (1991) (11)
Immunomodulatory effects of foreskin mesenchymal stromal cells on natural killer cells (2018) (10)
Impact of ATRA Duration during the Induction Treatment of Newly Diagnosed APL (2008) (10)
Circadian and circannual variations in cord blood hematopoietic cell composition (2015) (10)
SAR245409 Monotherapy in relapsed/refractory follicular lymphoma: preliminary results from the phase II ARD12130 study (2013) (10)
The Parma international randomized study in relapsed non Hodgkin lymphoma: 1st interim analysis of 128 patients (as 15 January 1991: 153 patients). (1991) (10)
Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers (2020) (10)
Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma (2015) (10)
Langerhans' cell histiocytosis associated with simultaneous lymphocyte predominance Hodgkin's disease and malignant melanoma. (1998) (10)
Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming (2012) (9)
Costs of haematological disease high and rising. (2016) (9)
Palifermin treatment in patients receiving high dose melphalan or beam prior to autologous peripheral blood stem-cell transplantation (2006) (9)
Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted management. (2004) (9)
Single-access transumbilical laparoscopic splenectomy using curved reusable instruments (2011) (9)
Mesenchymal Stromal Cells and Natural Killer Cells: A Complex Story of Love and Hate. (2019) (9)
Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs (2020) (9)
Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study (2012) (9)
Ex vivo myeloid differentiation of cord blood CD34+ cells: comparison of four serum-free media containing bovine or human albumin. (2003) (8)
NEUTROPENIA ASSOCIATED WITH EXCESS OF T CELL LYMPHOCYTES (1981) (8)
Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV). (1990) (8)
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro (1990) (8)
Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report (2006) (8)
Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells (2017) (8)
Increased incidence of lymphomas and carcinomas in patients with coeliac disease. (1998) (8)
Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly (2013) (8)
BHS Guidelines for the treatment of Burkitt’s lymphoma (2015) (8)
The respective usefulness of the G8 and a comprehensive geriatric assessment (CGA) to predict intolerance to chemotherapy and survival of fit and vulnerable older patients with hematological malignancies (2013) (7)
Perturbation of cytokine production by bone marrow stromal cells after cytomegalovirus infection (1993) (7)
Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta‐analysis (2017) (7)
Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction (2020) (7)
Biological basis of cancer-related anaemia (2001) (7)
Results of a Phase II Study with Bendamustine and Ofatumumab in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma (2011) (7)
Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stromal Cell (MSC) infusion for the Treatment of Metachromatic Leukodystrophy (MLD): A case report (2006) (7)
Innovative approach to older patients with malignant hemopathies (2016) (7)
Aging and malignant hemopathies (2015) (6)
Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells (2019) (6)
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study (2016) (6)
Rational therapeutic choice for older patients with lymphoma (2017) (6)
GRAFT-VERSUS-HOST DISEASE : REVIEW OF 22 CASES (2004) (6)
Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis. (2006) (6)
Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884 (2001) (6)
Marginal zone lymphomas: second most common lymphomas in older patients. (2019) (6)
Human marrow mesenchymal stem cell culture: serum‐free medium allows better expansion than classical alpha‐minimal essential medium (MEM) (2007) (6)
Myelofibrosis patients in Belgium: disease characteristics (2015) (6)
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. (1999) (6)
Preemptive Management of Epstein-Barr Virus Reactivation after Hematopoietic Stem Cell Transplantation. (2007) (5)
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma. (2013) (5)
Neopterin: an useful biochemical marker in the monitoring of allogeneic bone marrow transplantation. (1988) (5)
Identifying frailty in clinically fit patients diagnosed with hematological malignancies using a simple clinico-biological screening tool: The HEMA-4 study. (2021) (5)
BHS guidelines for the treatment of marginal zone lymphomas (2014) (5)
Long‐term follow‐up of 2 patients treated with 90Y‐rituximab radioimmunotherapy for relapse of nodular lymphocyte‐predominant Hodgkin lymphoma (2018) (5)
[Fatigue and quality of life in cancer patients]. (2002) (5)
Worldwide Examination of Patients with CLL Hospitalized for COVID-19 (2020) (5)
Arsenic Trioxide (ATO) Or ATRA For Consolidation Treatment Of Standard Risk Non Elderly Newly Diagnosed APL– Second Interim Analysis Of a Randomized Trial (APL 2006) By The French Belgian Swiss APL Group (2013) (4)
Preliminary Experience with Marcellomycin: Preclinical and Clinical Aspects (1982) (4)
An Aspergillus myocardial abscess diagnosed by echocardiography. (2008) (4)
Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials). (2005) (4)
Ex vivo expansion of neutrophil precursor cells from mobilized peripheral blood cells: similar results in cancer patients and normal donors. (2005) (4)
Stem cell transplantation in ALL : a donor versus no donor comparison in the EORTC ALL-4 study (2007) (4)
Use of CD 123 Expression on Blasts from AML, ALL and RAEB As Minimal Residual Disease Marker (2015) (4)
A randomized phase III study of elacytarabine versus limited investigator's choice in patients with refractory acute myeloid leukemia (AML). (2011) (4)
Pilot study of the DHAP rescue protocol and of a new conditioning regimen in responding NHL, at relapse (1989) (4)
Removal of tumour cells from bone marrow: overview. (1989) (4)
The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥ 70 years) patients with different cancer tumors. (2020) (4)
Infusion of peripheral blood stem cells collected at diagnosis, with maintenance of the treatment, resulted in Ph‐negative recovery in a chronic myeloid leukaemia patient in persisting aplasia on STI‐571 therapy (2002) (4)
Peripheral blood stem cells contamination in diffuse large cell (DLCL) and mantle cell (MCL) lymphomas: A quantitative comparison. (1998) (4)
Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies. (1991) (4)
Recombinant urate oxidase (Rasburicase) is safe and effective in managing hyperuricemia in children and adults: Results of a multi-national compassionate use trial. (2002) (4)
Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients (2019) (4)
Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic (2017) (4)
Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study (2017) (4)
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium (2019) (4)
Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL (2013) (4)
[Anemia in the elderly]. (2014) (4)
Triptorelin to prevent chemotherapy-induced ovarian failure in lymphoma patients: a prospective randomized study. (2013) (4)
Phase I-II evaluation of carminomycin in adults with acute leukemia. (1985) (3)
Controversies in the management of gastrointestinal non-Hodgkin's lymphomas. (1989) (3)
Role of chemotherapy for localized non-Hodgkin's lymphoma? (1987) (3)
Multicultural approaches of cancer pain. (2019) (3)
The potential of human bone marrow-derived mesenchymal stem cells to differentiate in neural cells (2000) (3)
White blood cell counts in a geriatric hospitalized population: A poor diagnostic marker of infection (2018) (3)
Human monoclonal antibodies: new approaches and perspectives in cancer. (1985) (3)
Quality of life, psychological, marital and work adjustment of hematologic malignancies survivors: a matched control study (2000) (3)
Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). (2019) (3)
Prognostic Value of Neuro-Psychological and Biological Factors in Clinically Fit Older Patients with Hematological Malignancies (2014) (3)
Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules (2021) (3)
Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugs. (1987) (3)
Are we ready for intercultural cancer care? (2018) (3)
Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center. (2004) (3)
Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results. (2005) (3)
[Cord blood: from bench to bedside]. (2008) (3)
Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association (2016) (3)
Pooled CRISPR Inverse PCR sequencing (PCIP-seq): simultaneous sequencing of retroviral insertion points and the associated provirus in thousands of cells with long reads (2019) (3)
Molecular evidence of a GVL effect in allogeneic transplant for acute lymphoblastic leukemia restricted to Ph-negative leukemia: Post-transplant immuno-modulation performed according to molecular follow-up seems efficient only in this subset of patients (2001) (3)
Early Discontinuation of Lenalidomide in Patients with Relapsing or Refractory Multiple Myeloma: Predictive Factors for Stopping in the Real Life (2016) (2)
Immunoprophylaxis of cytomegalovirus infections in transplanted patients. (1989) (2)
Modulation of the growth of hematopoietic human stem cells by growth factors: comparison of umbilical cord blood with bone marrow. (1993) (2)
Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma (2016) (2)
Differential sensitivity of normal marrow myeloid progenitor cells to mitoxantrone and bisantrene (1983) (2)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces apoptosis, downregulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells Running title: SAHA decreases CXCR4 and CLL cell migration (2009) (2)
New insight in the pathogenesis and treatment of CMV (1996) (2)
Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Single Centre Experience. (2007) (2)
PARMA international protocol (1991) (2)
Guidelines of the Belgian hamatological Society for newly diagnosed and relapsed follicular lymphoma 2012. (2012) (2)
Successful treatment with liposomal amphotericin B in two patients with persisting fungemia (1989) (2)
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol (2021) (2)
Incidence of CMV infection and cmv disease in allogeneic transplanted patients: from no prophylaxis to preemptive treatment (2000) (2)
[Hematopoietic stem cells: source, indications and perspectives]. (2002) (2)
Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis (2021) (2)
Chimeric antigen receptor T-cell lymphoma immunotherapy: the next questions. (2020) (2)
BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias (2016) (2)
Microvesicles and cancer (2013) (2)
A phase I clinical trial of recombinant human interleukine-6 (rhIL-6) in solid tumors (1992) (2)
Serum soluble CD23 is a prognostic marker in chronic lymphocytic leukemia (CLL) and stage IV lymphocytic lymphoma (LL) (1993) (2)
PF384 EFFECTIVENESS AND SAFETY OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ROUTINE CLINICAL PRACTICE: INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL-WORLD DATA (BIRD) STUDY (2019) (2)
Clinical response observed in a phase I study in T cell lymphoma patients treated with anti-CD70 SIMPLE Antibody ARGX-110. (2016) (2)
Oral prophylaxis with netilmicin in neutropenic cancer patients (1988) (2)
CLINICAL OUTCOMES WITH SINGLE-AGENT IBRUTINIB FOR RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL-WORLD DATA (BIRD) STUDY: PF494 (2019) (2)
Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis (2022) (2)
Quality of life (QoL) in older patients (pts) with cancer and prognostic factors for QoL decline. (2018) (2)
Diagnosis of congenital von Willebrand disease during a preoperative assessment in a multiple myeloma patient without bleeding history (2016) (2)
Suppressor cell induction and reticuloendothelial cells activation produced in the mouse by beta 1-3 glucan. (1979) (2)
[Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation]. (2018) (2)
[Prolidase deficiency. Apropos of a peculiar case]. (1989) (2)
A Pilot Study with an Ifosfamide, Carboplatin and Etoposide Regimen (ICE) in Patients with Advanced Non-Small-Cell Lung Cancer (1990) (2)
Flow cytometric analysis of oncogenic signal transduction pathways in primary leukaemic cells (2008) (2)
[Cardiac arrhythmias and superior vena cava syndrome revealing a Richter's syndrome]. (2014) (2)
Nonmyeloablative stem cell transplants: the Belgian Hematological Society Dose-finding Study (2002) (2)
Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures (2017) (2)
Manually assisted laparoscopic splenectomy for enlarged spleen (1997) (2)
Phase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma (2016) (2)
Frailty score of older patients with haematological malignancies: unsuspected role of mild cognitive impairment (2020) (2)
Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation (1997) (2)
MYC+ Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report (2011) (2)
Supportive care in bone marrow transplantation (1995) (1)
Excessive production of TGF-ß by bone marrow stromal cells in B-cell chronic lymphocytic leukemia (B-CLL) inhitits growth of hematopoietic precursors and IL-6 production by the stromal cells (1993) (1)
Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial. (2005) (1)
Use of alemtuzumab in B cell chronic lymphocytic leukaemia (CLL) : Belgian recommendations (2011) (1)
Hematopoietic Stem Cell Aging and Malignant Hemopathies (2020) (1)
Cytomegalovirus-mediated myelosuppression. (1993) (1)
Induction of apoptosis in human leukemic cells by ultrasonic low energy treatment (2000) (1)
Time to relapse and age-adjusted IPI have independent prognostic valve in aggressive lymphoma enrolled in the PARMA trial at first relapse (1998) (1)
Transplant related mortality after reduced intensity allogeneic stem cell transplantation below and above 60 y.o.: a BHS study (2005) (1)
[Contribution of immunologic surface markers to the differential anatomo-pathological diagnosis of malignant lymphomas (author's transl)]. (1981) (1)
Reply to Z. Blumenfeld et al. (2013) (1)
EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP (2021) (1)
DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATIENTS WITH FOLLICULAR, MANTLE AND T CELL LYMPHOMAS RELAPSING AFTER AN ALLOSCT. AN EBMT‐LWP STUDY (2019) (1)
High Dose (HD-AraC) vs Standard Dose Cytosine Arabinoside (SD-AraC) during Induction in Acute Myelogenous Leukemia (AML): Impact on Stem Cell Mobilization after Consolidation and on Autologous Transplantation (Second Report of the EORTC-Leukemia Group (LG) - GIMEMA AML-12 Trial. (2006) (1)
[Current management of marginal zone lymphomas]. (2015) (1)
PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads (2021) (1)
The micronome of mesenchymal stromal cells is partially responsive to inflammation (2018) (1)
[Extracorporeal photochemotherapy: review of its mechanisms of action and clinical applications]. (2007) (1)
Usefulness of a systematic geriatric screening in older cancer patients: a multicentric study in Belgium (2011) (1)
Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy induced anemia (2010) (1)
5.19 AMD3100 Disrupts Cross-talk Between Chronic Lymphocytic Leukemia Cells and Their Microenvironment: Preclinical Evidence for Its Association with CLL Treatments (2011) (1)
Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience. (2007) (1)
Monoclonal antibody fluorescence for blasts detection, quantification and lineage identification with an automated hematology analyser Abbott-CELL-DYN Sapphire: comparison with flow cytometry and morphology (2008) (1)
Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report (2008) (1)
Effect of alpha and gamma interferon on CFU-GM. (1986) (1)
Myelomonocytic antigen abnormalities on neutrophils and monocytes in myelodysplastic syndromes (1994) (1)
499 Phase 2a study of copanlisib, a novel phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma (2014) (1)
The role of GM-CSF in adult haplo-identical tranplant who cannot benefit from NK allo-reactivity (2005) (1)
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study. (2022) (1)
Prognostic value of neuropsychological and biological factors in older patients with hematological malignancies admitted to receive chemotherapy (2014) (1)
Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells (2016) (1)
Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming (2017) (1)
Abstract PR10: Active and quiescent tertiary lymphoid structures, differentiated using FOXP1 expression, play a role in immunity to breast cancer (2020) (1)
Arsenic Trioxide (ATO) and ATRA with Limited Chemotherapy (CT) in Newly Diagnosed Standard Risk APL in the Elderly. a Report By the French Belgian Swiss APL Group (APL 2006 trial) (2016) (1)
Waldenström’s macroglobulinaemia : Belgian Hematology Society guidelines (2015) (1)
O07 Dexamethasone versus methyl-prednisolone for adult acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL) in patients ≤60 yrs old: final results of the EORTC ALL-4 Phase III Trial (2007) (1)
G8 or Multimodal Geriatric Assessment (MGA) for the screening of older patients with malignant hemopathies (2012) (1)
Comparison of Laparoscopic Splenectomy Outcomes for Benign and Malignant Hemopathies. (2020) (1)
Relative effects of carminomycin (CMM), adriamycin (ADM) and daunomycin (DNM) in normal myeloid and leukemic clonogenic assays (1982) (1)
Challenges and potential in regenerative medicine: A joint report from EASAC and FEAM (2020) (1)
Fatigue et cancer (2011) (1)
Ex Vivo Expansion of Human Marrow Mesenchymal Stem Cells: A Serum-Free Medium Compared to Classical α-MEM Medium. (2004) (1)
Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia , mantle cell lymphoma and Waldenström macroglobulinemia anno 2018 (2018) (1)
Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia , mantle cell lymphoma and Waldenström macroglobulinemia anno 2018 (2018) (1)
Low energy laser irradiation for the treatment of chemotherapy induced mucositis in bone marrow stem cell transplanted patients (2002) (1)
Reply to M. Lambertini et al. (2017) (1)
Corrigendum to "Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]. (2016) (1)
Treatment of Peripheral T-cell Lymphomas: recommendations of the Belgian Hematological Society (2013) (1)
GnRH agonists, is their evidence for a protective effect on the ovary ? (2006) (1)
Spontaneous hyperuricemic acute renal failure. (1987) (1)
Lymphome non hodgkinien (2001) (1)
Clofarabine in combination with a standard remission induction regimen in patients 18-60 years old previously untreated intermediate an bad risk actue myelogenous leukemia (AML) or high risk myelodysplasia (MDS): combined phase I/II results of the EORTC/Gimema AML-14A trial (2014) (1)
Aging and Malignant Hemopathies: A Complex Multistep Process (2018) (1)
OP08 High dose (HD-AraC) vs standard dose cytosine arabinoside (SD-AraC) during induction in acute myelogenous leukemia (AML): Impact on stem cell mobilization after consolidation and on autologous transplantation (AML-12 trial) (2007) (1)
Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review (2023) (1)
Ex vivo expansion of myeloid progenitor cells from mobilized peripheral blood: normal donors versus pretreated patient (2004) (0)
MicroRNA-29c and 223 Are Powerful Prognostic Factors for Chronic Lymphocytic Leukemia and Improve Risk Stratification When Combined with ZAP70 and LPL in a qPCR Score (2008) (0)
Valproate, a Histone Deacetylase Inhibitor, Enhances Purine Nucleoside Analogues Induced Apoptosis of B-Chronic Lymphocytic Leukemia Cells. (2007) (0)
Acute Myeoloid Leukemia in the elderly: Role of age and cytogenetic data in the outcome of fit patients (2010) (0)
A Retrospective Analysis of Brentuximab Vedotin and Pembrolizumab Combination As Salvage Treatment for Patients with Relapsed or Refractory Hodgkin Lymphoma (2020) (0)
ATG in non-myeloablative stem cell transplant: a national dose-finding study (2003) (0)
[Basophil leukemia, development of a chronic myeloid leukemia. Apropos of a case and review of the literature]. (1987) (0)
Efficacy of peripheral stem cell mobilization after fludarabine treatment in bad prognosis CLL patients: results from a prospective multicenter trial conducted by the Belgian Hematological Society (BHS) (2001) (0)
Cord blood CD34+ cells do not differentiate successfully in megakaryocytes in vitro as compared with mobilized peripheral blood cells: negative effects of the addtion of stem cell factor to thrombopoietin (2003) (0)
P726 Usefulness of a general chemotherapy myelotoxicity score to predict febrile neutropenia in haematological cancers (2007) (0)
[The contribution of monoclonal antibodies to the diagnosis and prognosis of acute leukemias (apropos of 100 cases)]. (1988) (0)
Colony-stimulating factors: current applications and perspectives. (1995) (0)
The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group – Oral Session (2019) (0)
Imaging 413 IN VIVO EVALUATION BY IMMUNO-PET/CT OF THE IMPACT OF A PRELOAD WITH COLD ANTIBODIES ON THE DISTRIBUTION OF RADIOLABELED ANTIBODIES (2011) (0)
Geriatric vulnerabilities and their impact on survival in older patients at the initiation of cancer treatment: major impact of cognition. (2015) (0)
Cytogenetic and molecular testing in lymphoma patients (2018) (0)
Basophilic leukemia: case report and review of the literature (1987) (0)
[Rational approach of leucocytosis in adults]. (2013) (0)
Rapid induction of apoptosis in human myeloid leukemic cells as a result of sonochemical effects generated by low energy ultrasonics: A promising tool (2001) (0)
Y-rituximab in CD20+ B-cell lymphoma as predicted by Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab (2015) (0)
[Mastocytosis: revisited with new cytogenetic data]. (2012) (0)
Ex Vivo Expansion of Mobilized Peripheral Blood Myeloid Progenitor Cells: Pretreated Patients vs Normal Donors. (2004) (0)
BACH2 AND FOXP1 GENE EXPRESSIONS ARE SIGNIFICANTLY ALTERED IN T AND B CELLS FROM CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO AGED-MATCHED HEALTHY DONORS IMPACTING SURVIVAL (2019) (0)
The usefulness of the G8 screening tool for identification of vulnerable older patients with hematological malignancies susceptible to benefit from chemotherapy (2013) (0)
FOXP1, PD‐1 AND PD‐L1 ARE SIGNIFICANTLY UPREGULATED IN LYMPHOCYTES FROM CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO AGE‐MATCHED HEALTHY DONORS (2019) (0)
Hospitalizations, emergency department visits and home care in older patients after cancer diagnosis: results from a large data linkage study with 3 year follow-up (2022) (0)
[Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs]. (2015) (0)
Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients (2019) (0)
Primary cerebral lymphomas in 48 immunocompetent patients: retrospective analysis and prospective therapeutic strategy (1997) (0)
Chronic Lymphocytic Leukemia (CLL): new insight on the pathogenesis of CLL cell survival (2002) (0)
Abstract 3995:BACH2andPRDM1gene expression changes in T and B cells according to age of healthy individuals and significance in chronic lymphocytic leukemia patients (2019) (0)
G8 as a screening tool for older patients with malignant hemopathies: A surrogate of CGA? (2012) (0)
PF368 DYSREGULATION OF BACH2 AND FOXP1 GENES IN T AND B CELLS IS MORE PRONOUNCED IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO AGED-MATCHED HEALTHY DONORS WITH AN IMPACT ON SURVIVAL (2019) (0)
Growing evidences that the Comprehensive Geriatric Assessment (CGA) can predict outcome in older cancer patients with malignant hemopathies (2011) (0)
Do we need to address cross-cultural issues in EBMT ? (2017) (0)
Ex vivo myeloid differentiation of CD34+ progenitor cells from fresh or cryopreserved cord blood samples (2001) (0)
How to predict poor outcome in older patients receiving chemotherapy for malignant lymphoma: a new frailty scoring (2016) (0)
Title: A Randomized Study of Interferon Alpha-2b Versus no Treatment as Consolidation (2013) (0)
Gene expression profiles based on ZAP70 mRNA levels (2008) (0)
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study (2022) (0)
[Bone marrow autograft in malignant hemopathies. The Team of the Sterile Unit]. (1992) (0)
Elderly cancer inpatient’s desire for psychological support during the diagnostic phase or before a new treatment line: prevalence and implications for screening psychological needs. (2011) (0)
The Histone Deacetylase Inhibitor SAHA Induces Caspase-Dependent Apoptosis in Chronic Lymphocytic Leukemia Cells. (2005) (0)
Long-Term Overall and Event-Free Survival after RIC Allogeneic Transplantation in Acute Leukemias in a Single Centre - Impact of Age and Donor Type? (2015) (0)
A Multirefractory Lymphomatoid Granulomatosis Successfully Treated with Gemcitabine as a Single Agent: Case Report and Review of the Literature (2021) (0)
Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study. (2004) (0)
Recombinant Human Erythropoietin in the Anemia Associated With Multiple Myeloma or Non-Hodgkin’s Lymphoma: Dose Finding and Identification (2000) (0)
Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells (2017) (0)
CD133 Positive Mesenchymal Stem Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression and Plasticity. (2004) (0)
Geriatric screening and assessment among older patients with cancer: evaluation of long-term outcomes in a multicentric cohort of > 7, 000 patients (2021) (0)
or R-DHAP followed by BEAM plus autologous stem cell transplantation diffuse large B-cell lymphoma is not salvaged by classical R-ICE + MYC (2012) (0)
A prognostic values of blood coagulation parametrs in patientsundergoing bone marrow transplantation (1993) (0)
Identification of the Microrna Signature of Acute Myeloid Leukemia Patient s Regulatory T Lymphocytes (2015) (0)
Gene expression profiling of CD4+ T cells infiltrating human breast carcinomas identified CXCL13-producing T follicular helper cells associated with tertiary lymphoid structures and better patient outcome: identification des cellules T auxiliaires folliculaires produisant CXCL13, associées aux struc (2012) (0)
Association of low expression of VEGF121 soluble isoform with prognostic impact and survival in patients with activated B-cell-like (ABC-like) diffuse large B-cell lymphoma (DLBCL) from the CORAL trial. (2012) (0)
Immunological impact of Wharton’s Jelly mesenchymal stromal cells and natural killer cell co-culture (2018) (0)
comparison of French-Belgian-Swiss and PETHEMA results Treatment of newly diagnosed acute promyelocytic leukemia (APL): a (2013) (0)
Approche rationnelle d'une hyperleucocytose. (2013) (0)
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives]. (1985) (0)
[Myelodysplastic syndromes]. (1985) (0)
Anaemia in older persons (2014) (0)
Section Review: Biologicals & Immunologicals: New insights into the pathogenesis and treatment of cytomegalovirus (1996) (0)
Cytokines and Chemokines Involved in the Inflammatory Process Have Potent Chemoattractive Properties on MSC. (2006) (0)
Fludarabine phosphate-based reduced intensity conditioning for allogeneic stem cell transplantation in patients with acute myeloid leukemia, myelodysplasia and chronic myeloid leukemia: Update of a national dose-finding study (2007) (0)
Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming (2012) (0)
Two doses of ATG in fludarabine phosphate-based RIC transplant for lymphoproliferative diseases: A BHS study (2005) (0)
[Intensive chemotherapy and bone marrow autograft in malignant lymphomas (author's transl)]. (1982) (0)
Induction of apoptosis in B-cells from chronic lymphocytic leukemia (B-CLLS) by CD47 (1998) (0)
The respective value of the G8 screening and the Comprehensive Geriatric Assessment (CGA) for the identification of vulnerable older patients with hematological malignancies susceptible to benefit from chemotherapy (2014) (0)
Cell-killing profile of thymoquinone toward malignant B lymphocytes from diffuse large B cell lymphoma and underpinning mechanisms (2017) (0)
Fatal lactic acidosis in malignant histiocytosis. (1986) (0)
[Malignant or benign hyperleukocytosis ?] (2018) (0)
Predicting bacteraemia following chemotherapy administration in patients with hematological cancer (HC) (2007) (0)
Polypoid colon mucosa in a leukemia patient. (2022) (0)
Phase I-II of a THC analog (BRL 4664) in the prevention of CDDP induced vomiting (1981) (0)
Microrna-29c and 223 and Their Prognostic Value in Chronic Lymphocytic Leukemia (2009) (0)
Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts (2018) (0)
Stem cell factor and interleukjn 3 receptor expression on CD34+CD38+ ANDCD34+CD38+ cells from umbilical cord blood and mobilized peripheral blood (1998) (0)
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives (2004) (0)
[Non Hodgkin's lymphomas: a major breakthrough with immunotherapy]. (2011) (0)
Anti-thymocyte globulin (ATG) in fludarabine phosphate-based nonmyeloablative stem cell transplantation: A national dose-finding study. (2003) (0)
The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity. (2005) (0)
Abstract of the Meeting of the Belgian Society of Heamotology (December 13 1986) (1987) (0)
Long-term survival after reduced-intensity allogeneic transplantation for advanced lymphoproliferative disorders (2011) (0)
Acute worsening of retinal lesions during oral steroid treatement in a case of intracular lymphoma (2012) (0)
Lymphomes non hodgkiniens (2011) (0)
3129 – IMPACT OF AGING ON THE BIOLOGICAL PROPERTIES OF BONE MARROW MESENCHYMAL STROMAL CELLS. (2022) (0)
Identification of clinical and biological parameters predictive of chemotherapy completion and two-year overall survival in clinically fit older patients with haematological malignancies (2016) (0)
Long (GT)n repeat in the promoter region of heme oxygenase-1 is associated with severe graft-versus-host disease (2014) (0)
Cytogenetic and molecular testing in lymphoma patients Part 2 : Aberrations in aggressive B-cell lymphomas , Hodgkin lymphoma , and T and NK lymphomas PRACTICE GUIDELINES (2018) (0)
CLL patient comparison according to Zap70 mRNA level: new prognostic factors, differences in microRNA expression and distinct interaction capacities with the microenvironment (2008) (0)
Hepatosplenic T-cell lymphoma: treatment challenges (2021) (0)
Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes. (2023) (0)
Efficiency and cutaneous adverse effects of alemtuzumab (CAMPATH: anti-CD-52 monoclonal antibody) in a patient with T-cell prolymphocytic leukemia and erythroderma (2013) (0)
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance (2016) (0)
Hydroxychloroquine (Hcq) Induces apoptosis in b-chronic lymphocytic leukemia cells (B-cll) Via activation of CASPASE-3 and down-regulation of BCL-2 (2000) (0)
miRNA Profile and Role in the Immunological and Inflammatory Microenvironment of the Stroma (2020) (0)
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study (2022) (0)
[Adoptive immunotherapy with interleukin 2. Initial results of a pilot study in 6 cancer patients]. (1989) (0)
Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry (2016) (0)
Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis (2014) (0)
Role of ATG in fludarabine phosphate-based nonmyeloablative stem cell transplantation: a national dose-finding study (2004) (0)
Expression of adhesion molecules on CD34+ cells does not correlate with property to adhere to normal marrow-derived stroma (2000) (0)
CALRETICULIN V/S JAK2 MUTATION CHARACTERISTICS IN ESSENTIAL THROMBOCYTOSIS IN ASIAN AND NON-ASIAN POPULATION: A META-ANALYSIS (2015) (0)
Comparison of chronic lymphocytic leukemia patients expressing high or low level of ZAP70 mRNA: new prognostic factors differences in microRNA expression and interaction with the microenvironment (2008) (0)
Prediction of Poor Outcome in Older Patients Receiving Chemotherapy for Malignant Lymphoma: A New Frailty Scoring (2016) (0)
EORTC Leukemia Group achievements (2012) (0)
Rapid clearance of BCR-ABL transcripts after tcell depleted stem cell transplantation for cml: a role of increased immune suppression of the recipient? (2001) (0)
1265MO Cause and place of death in older patients with cancer: Results from a large cohort study using linked clinical and population-based data (2022) (0)
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013) (2015) (0)
Prognostic value of KI‐67, MIPI score and SUV MAX of the PET scan: Result of a single center experience with mantle‐cell lymphomas (2017) (0)
PS1517 MILD COGNITIVE IMPAIRMENT, HYPOALBUMINEMIA, HIGH CRP AND GASTRO-INTESTINAL ULCER: 4 MARKERS OF FRAILTY WHICH IDENTIFY OLDER PATIENTS WITH MALIGNANT HEMOPATHIES WHO DON’T BENEFIT FROM CHEMOTHERAPY (2019) (0)
Abstract 3853: The anti-tumor immune responses by active and quiescent tertiary lymphoid structures to breast cancer (2020) (0)
Syngeneic transplants Stem cell transplantation from identical twins in patients with myelodysplastic syndromes (2005) (0)
Impact of life-threatening information on the evolution of patients’ anxiety and risk recall: The specific context of informed consent for experimental stem cell transplant (2006) (0)
‘ ‘ focus on . . . ’ ’ session : CLL 021 POLYMORPHISMS IN APOPTOTIS AND IMMUNOREGULATORY RELATED GENES ARE ASSOCIATED WITH AN INCREASED RISK OF CHRONIC LYMPHOCYTIC LEUKEMIA ( CLL ) (2008) (0)
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis (2016) (0)
Valproic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells by Targeting Several Pro- and Anti-Apoptotic Genes. (2007) (0)
Reduced Rates of B Cell Proliferation in Chronic Lymphocytic Leukemia. (2006) (0)
Ibrutinib: A major breakthrough in the treatment of CLL and other lymphoproliferative disorders (2013) (0)
Effect of the Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) On Chronic Lymphocytic Leukemia Cells: Apoptosis, Migration Impairment and Drug Sensitization. (2009) (0)
THE SOURCE OF HUMAN MESENCHYMAL STROMAL CELLS INFLUENCES THEIR TLR PROFILE AS WELL AS THEIR FUNCTIONAL PROPERTIES: 1307 (2010) (0)
Suppressor cells induction and re cells activation produced in the mouse by beta1-3 glucan. Abstr. (1978) (0)
Risk of infectious and non-infectious complications during the first cycle of chemotherapy in patients aged 65 or older: preliminary results from Institut Jules Bordet (2013) (0)
Effect of alpha and gamma interferon on CFU-GM [letter] (1986) (0)
Donor lymphocytes infusion in adult haplo-identical transplant: A dose finding study (2001) (0)
Peripheral blood progenitor cell collection after docetaxel and lenograstim in patients with metastatic breast cancer (1998) (0)
University of Groningen Standard chemotherapy with or without high-dose chemotherapy for aggressive non- Hodgkin's lymphoma Kluin-Nelemans, (2000) (0)
[Adoptive immunotherapy: a new therapeutic approach to cancer based on interleukin 2]. (1987) (0)
Non-myeloablative stem cell transplant: A dose-finding study (2002) (0)
Inolimomab in steroid-resistant aGvHD 1 A phase III randomized trial comparing Inolimomab vs . Usual care in steroid-resistant acute GVHD (2016) (0)
Prophylaxis of bacterial infections with netilmicin and spiramycin in granulocytopenic patients (1989) (0)
[Monitoring amiodarone]. (1983) (0)
Approche rationnelle d'une hyperleucocytose Rational approach of leucocytosis in adults (2013) (0)
Ex Vivo Proliferation and Differentiation of CD34+ Cells into Myeloid Progenitor Cells: Cord Blood Versus Mobilized Peripheral Blood. (2006) (0)
Impact of aging on the biological properties of bone marrow mesenchymal stromal cells (2022) (0)
Chimeric antigen receptor T-cells: a new therapeutic option for relapsed/refractory B-cell malignancies and beyond (2019) (0)
Implementation of geriatric assessment in Belgian patients with cancer: A multicenter survey on treating physicians' general experiences and expectations (2014) (0)
How to identify older cancer patients who should benefit from comprehensive geriatric assessment (2012) (0)
Delayed donor lymphocyte infusions, cryopreserved from the initial G-CSF stimulated apheresis, in adult haplo-identical transplants (2001) (0)
[Value of monoclonal antibodies in the diagnosis and treatment of cancer]. (1984) (0)
Chronic Lymphocytic Leukemia: which prognostic factor to choose? (2007) (0)
Zap-70 mRNA expression quantified in B cell by real time PCR is a powerful prognostic factor in Chronic Lymphocytic Leukemia (2007) (0)
Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT (2020) (0)
Transcription Factors and Checkpoint Inhibitor Expression with Age: Markers of Immunosenescence? (2016) (0)
Allogeneic transplantation for adult acute lymphoblastic leukemia: Intention to treat analysis of the EORTC ALL-4 phase III trial (2006) (0)
Gene expression comparison between B cells expressing high and low level of Zap-70 mRNA reveals distinct profiles, potential therapeutic targets and new prognostic factors for Chronic Lymphocytic Leukemia (2007) (0)
Doubling Time of Soluble CD23 Is an Additional Prognostic Factor in ZAP 70 Positive CLL Patients. (2005) (0)
transplantation involved- field radiotherapy and BEAC with autologous bone marrow Parma international protocol: pilot study of DHAP followed by (2011) (0)
Splénectomie par abord mixte: coelioscopie et dexterity glove (1996) (0)
Altered Cognitive Compensatory Mechanisms in an Elderly Cancer Patient Population Undergoing Chemotherapy: A Longitudinal Study (2014) (0)
BHS guidelines for the treatment of chronic lymphocytic leukaemia anno 2012 (2012) (0)
Yttrium-90 Microsphere Radioembolization of the Spleen: A New Approach for the Treatment of Malignant Lymphomatous Splenomegaly (2009) (0)
[Euthanasia, four propositions of the Consultant Committee on Bioethics]. (1998) (0)
Production of human monoclonal antibodies (MoAb) against cytomegalovirus (CMV) antigen (1986) (0)
Ibrutinib vs Clorambucilo-Burger-2015-e-pub (2016) (0)
Activation of mouse peritoneal macrophages by 1.3 glucan and its sensitivity to antimacrophage serum (1980) (0)
Waldenström Macroglobulinemia: new Classification and Therapeutic Options (2011) (0)
Concomitant or Sequential Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML): A Molecular and Clinical Survey (2009) (0)
[In honor of Professor Philippe Martiat]. (2015) (0)
External validation of the HEMA-4 score: a simple clini-co-biological tool to identify frailty in clinically fit older patients with hematological malignancies (2022) (0)
Campath-1H: a highly effective therapy in T-cell prolymphocytic leukemia (2011) (0)
Suppl-Resonate-2-Burger-2015 (2016) (0)
How much is cognitive functioning related to the psychological adaptation of elderly cancer patients: a longitudinal prospective multicentre study (2012) (0)
Underestimated impact of mild cognitive impairment in « clinically fit » older patients with malignant hemopathies admitted to receive chemotherapy (2015) (0)
DETECTING UNSUSPECTED FRAILS PATIENTS WITH A SIMPLE CLINICO-BIOLOGICAL TOOL AMONG ELDERLY PATIENTS SUFFERING FROM HEMOPATHIES: THE HEMA-4 STUDY (2019) (0)
Spontaneous hyperuricemic acute renal failure on oncologic emergency (1987) (0)
Sinusitis in allogeneic stem cell transplant: A prospective survey of its incidence and impact on morbidity and mortality (2001) (0)
Fludarabine phosphate-based nonmyeloablative stem cell transplantation in the elderly patients: A BHS study (2004) (0)
Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation (2018) (0)
A scientific survey studying the Belgian myelofibrosis patient population according to study specific disease parameters (2012) (0)
New therapeutic approaches in cutaneous T-cell lymphomas. (2017) (0)
[The treatment with prostaglandin E1 of a suspected hepatic veno-occlusive disease in a leukemic patient]. (1988) (0)
ANALYSIS OF POTENTIAL INTERACTIONS BETWEEN DRUG TREATMENTS AND OVER-THE-COUNTER MEDICATIONS TAKEN BY OLDER PATIENTS WITH SOLID TUMORS OR HEMATOLOGICAL MALIGNANCIES (2019) (0)
Does Gonadotropin-releasing hormone agonists prevent, chemotherapy induced premature ovarian failure in women with malignant lymphoma? (2013) (0)
Follow-Up Results of a Prospective, Multicenter, Open-Label Study of Oral Fludarabine Phosphate in Patients with Previously Untreated B-CLL. (2005) (0)
Cognitive impairment predicts two-years total mortality in elderly onco-surgical patients (2015) (0)
[The role of exploratory laparotomy and splenectomy in malignant lymphomas]. (1987) (0)
“Sense of being a burden to the primary caregiver” in elderly patients with hematologic malignancies who start a chemotherapy treatment (2012) (0)
A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110 (2016) (0)
Infections (viral) (2002) (0)
[Therapeutic aspects of cyclosporin in hematology]. (1985) (0)
Cognitive Impairment, Hypoalbuminemia, High CRP Level and Past History of Gastro-Intestinal Ulcer: 4 Markers of Frailty Which Identify Older Patients with Malignant Hemopathies Who Shouldn't Benefit from Chemotherapy (2018) (0)
RARS-T without Thrombocytosis?. (2007) (0)
Hepatosplenic Gamma‐Delta T‐Cell Lymphoma, a Rare and Challenging Diagnosis: NHL‐258 (2018) (0)
Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules (2021) (0)
Ex vivo expansion of cord blood and mobilized peripheral blood CD34+ cells into megakaryocytes: detrimental effect of Flt3-ligand, stem cell factor and interleukin 3 (2003) (0)
[Treatment of non-Hodgkin's lymphomas (author's transl)]. (1982) (0)
Management of fit older AML: Major prognostic value of cytogenetic markers is confirmed whatever the age (2012) (0)
Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study (2016) (0)
Laparoscopic Splenectomy for Hematologic Disorders: A Safe Procedure. (2006) (0)
Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study (2022) (0)
Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma (2014) (0)
Prospective nutritional survey of older patients receiving heavy treatment for malignant hemopathies (2008) (0)
Autologous bone marrow transplantation for acute leukemia using ferromagnetic microparticles and monoclonal antibody-purged marrows: demonstration of effectiveness by polymerase chain reaction. (1992) (0)
Infusion of Mesnchymal Stem Cells (MSC) in Patients with Poor Hematopoietic Recovery after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): A Pilot Study. (2006) (0)
Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming (2012) (0)
Improving the bioinformatics analysis of HTS clonality data in virus-induced leukemia (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dominique Bron?

Dominique Bron is affiliated with the following schools:

Dominique Bron's Academic­Influence.com Rankings

Dominique Bron's Degrees

Similar Degrees You Can Earn

Why Is Dominique Bron Influential?

Dominique Bron's Published Works

Published Works

What Schools Are Affiliated With Dominique Bron?

Dominique Bron's AcademicInfluence.com Rankings